Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Kaneka Develops Technology to Efficiently Prepare SVF From Adipose Tissue

Filed Under: Industry, Pharma Tagged With: , , , , ,

Kaneka Corp. (TYO:4118) is making moves to expand its business for regenerative medicine. Having previously developed a cell concentration and…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Kaneka Looks to Boost Health Care Business Sales to 300B Yen With New Medical Products
Kaneka Looks to Boost Health Care Business Sales to 300B Yen…
Nissan Chemical Eyes Global Expansion of High-Performance, Cost-Effective Cell Culture Supplement
Nissan Chemical Eyes Global Expansion of High-Performance,…
Sumitomo Chemical to Go Full-Scale Into Antiviral Market
Sumitomo Chemical to Go Full-Scale Into Antiviral Market
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…
Mitsubishi Chemical to Produce Regenerative Medicine Materials From Plants
Mitsubishi Chemical to Produce Regenerative Medicine…
Kaneka Develops Biodegradable Polymer for the Inside of Paper Cups
Kaneka Develops Biodegradable Polymer for the Inside of…